- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Mark E. Strome
- Signature - Title
- /s/ Mark E. Strome - Mark E. Strome
- Location
- Santa Monica, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Mark E. Strome.
Follow Filing Activity
Follow Mark E. Strome and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Mark E. Strome
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZIVO | Zivo Bioscience, Inc. | Common Stock, par value $.001 per share | 12% | $53,142 | 442,854 | Mark E. Strome | 26 Dec 2024 | ||
| ZIVO | Zivo Bioscience | Common Stock, par value $.001 per share | 12% | 472,942 | Mark E. Strome | 31 Dec 2025 | |||
| CUE | Cue Biopharma, Inc. | Common Stock, $0.001 par value per share | 5% | $1,862,968 | 2,166,242 | Mark E. Strome | 14 Nov 2022 |
Schedules 13D/G Reported by Mark E. Strome:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.